A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact

Autor: Locati, L.D., Perrone, F., Cortelazzi, B., Bergamini, C., Bossi, P., Civelli, E., Morosi, C., Lo Vullo, S., Imbimbo, M., Quattrone, P., Dagrada, G.P., Granata, R., Resteghini, C., Mirabile, A., Alfieri, S., Orlandi, E., Mariani, L., Saibene, G., Pilotti, S., Licitra, L.
Zdroj: In European Journal of Cancer December 2016 69:158-165
Databáze: ScienceDirect